Background The gut microbiota has been linked to non-communicable diseases, including chronic kidney disease (CKD). However, the relationships between gut microbiome composition changes, uraemic ...

On June 17, Mineralys Therapeutics, Inc. (NASDAQ:MLYS) reported positive topline data from its Phase 2 Explore-CKD trial of lorundrostat.

The intensity of CKD-aP is linked to levels of systemic inflammation, with reductions in these levels seen with difelikefalin treatment.

TUESDAY, June 24, 2025 (HealthDay News) — A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study published in the June issue of the ...

The chronic kidney disease-mineral bone disorder (CKD-MBD) is a complex multi-component syndrome occurring during kidney disease and its progression. Here, we update progress in the components of the ...